172 related articles for article (PubMed ID: 7519092)
1. Low molecular weight heparin: laboratory properties and clinical evaluation. A review.
Hirsh J; Levine MN
Eur J Surg Suppl; 1994; (571):9-22. PubMed ID: 7519092
[No Abstract] [Full Text] [Related]
2. Strategy for the development of the low molecular weight heparin fraction CY 216 in the prevention of postoperative deep vein thromboses in general surgery.
Toulemonde F
Semin Thromb Hemost; 1989 Oct; 15(4):395-400. PubMed ID: 2554500
[TBL] [Abstract][Full Text] [Related]
3. Treatment of venous thromboembolism: unfractionated heparin or low molecular weight heparins?
Agnelli G
Haematologica; 1995; 80(2 Suppl):78-83. PubMed ID: 7628776
[No Abstract] [Full Text] [Related]
4. Review of clinical trials of low molecular weight heparins.
Bergqvist D
Eur J Surg; 1992 Feb; 158(2):67-78. PubMed ID: 1350218
[No Abstract] [Full Text] [Related]
5. [Development of the low molecular weight heparin fraction CY 216 in the prevention of postoperative thrombosis in general surgery].
Toulemonde F
Therapie; 1988 May; 43(3):187-92. PubMed ID: 2844004
[No Abstract] [Full Text] [Related]
6. Thromboprophylaxis with heparin and low molecular weight heparin in elective hip surgery: current status and perspectives.
Breyer HG
Semin Thromb Hemost; 1991 Oct; 17(4):336-42. PubMed ID: 1666453
[No Abstract] [Full Text] [Related]
7. Low molecular weight heparins and bleeding.
Breddin HK
Semin Thromb Hemost; 1989 Oct; 15(4):401-4. PubMed ID: 2479104
[No Abstract] [Full Text] [Related]
8. Prophylaxis of postoperative deep vein thrombosis in general surgery: experiences with Fragmin.
Bergqvist D
Acta Chir Scand Suppl; 1988; 543():87-9. PubMed ID: 2847463
[No Abstract] [Full Text] [Related]
9. Enoxaparin--a low-molecular-weight heparin.
Med Lett Drugs Ther; 1993 Aug; 35(903):75-6. PubMed ID: 8393510
[No Abstract] [Full Text] [Related]
10. Prevention of post-operative thrombosis by low molecular weight heparin in patients undergoing hip replacement.
Thomas DP
Thromb Haemost; 1992 May; 67(5):491-3. PubMed ID: 1325677
[No Abstract] [Full Text] [Related]
11. Low-molecular-weight heparin vs. warfarin for prophylaxis against deep-vein thrombosis.
Hirsh J
N Engl J Med; 1994 Mar; 330(12):862-3. PubMed ID: 8114845
[No Abstract] [Full Text] [Related]
12. Ex-vivo and in-vitro evidence that low molecular weight heparins exhibit less binding to plasma proteins than unfractionated heparin.
Young E; Wells P; Holloway S; Weitz J; Hirsh J
Thromb Haemost; 1994 Mar; 71(3):300-4. PubMed ID: 8029793
[TBL] [Abstract][Full Text] [Related]
13. Low molecular weight heparin(s).
Barrowcliffe TW
Br J Haematol; 1995 May; 90(1):1-7. PubMed ID: 7786769
[No Abstract] [Full Text] [Related]
14. Dihydroergotamine-heparin to prevent postoperative deep vein thrombosis.
Med Lett Drugs Ther; 1985 May; 27(688):45-6. PubMed ID: 3889570
[No Abstract] [Full Text] [Related]
15. Prophylaxis of venous thromboembolism: the old and the new.
Pini M
Haematologica; 1995; 80(2 Suppl):66-77. PubMed ID: 7628774
[No Abstract] [Full Text] [Related]
16. [Clinical relevance of preventing thrombosis with heparin and heparinoids].
Zimmermann RE; Rogge H; Schwering H; Bünte H
Med Welt; 1982 Mar; 33(11):408-9. PubMed ID: 6177998
[No Abstract] [Full Text] [Related]
17. The relationship between ex vivo anti-factor Xa levels and efficacy/safety of low molecular weight heparin.
Turpie AG
Br J Clin Pract Suppl; 1989 Jan; 65():18-23; discussion 23-5. PubMed ID: 2554949
[No Abstract] [Full Text] [Related]
18. Prevention of deep vein thrombosis--use of the low molecular weight heparin enoxaparin.
Forbes CD
Br J Clin Pract; 1989 Nov; 43(11):396-400. PubMed ID: 2558702
[No Abstract] [Full Text] [Related]
19. Uses of heparin.
Chesterman CN; Chong BH
BMJ; 1993 Apr; 306(6882):871-2. PubMed ID: 8387843
[No Abstract] [Full Text] [Related]
20. Low molecular weight heparins for DVT.
Ebell MH
J Fam Pract; 1994 Nov; 39(5):501-2. PubMed ID: 7964550
[No Abstract] [Full Text] [Related]
[Next] [New Search]
